首页> 外国专利> Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome

Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome

机译:治疗免疫介导的登革热感染和抗体依赖性增强登革热感染的方法,包括登革热出血热和登革热休克综合征

摘要

Polypeptides and other compounds that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule, as well as methods for using such polypeptides and compounds to inhibit Fc-mediated immune complex formation in viral infection, are described. For example, polypeptides and other compounds can be used to inhibit binding of DF-associated, immune-complexed IgG anti-DF viron(s) or DV viral antigens to FγR, ADE of DF/DHF/DSS infections by inhibition of DF viral antigen binding to immune complexed IgG, FγR and immune complexed IgG mC1q (membrane C1q) or soluble C1q binding.
机译:可以与免疫球蛋白分子的C H 2-C H 3裂口特异性结合的多肽和其他化合物,以及使用此类多肽和化合物抑制Fc的方法介导的病毒感染中免疫复合物的形成。例如,多肽和其他化合物可用于通过抑制DF病毒抗原来抑制DF相关的免疫复合IgG抗DF病毒或DV病毒抗原与DF / DHF / DSS感染的FγR,ADE结合与免疫复合IgG,FγR和免疫复合IgG mC1q(膜C1q)或可溶性C1q结合结合。

著录项

  • 公开/公告号US8815813B2

    专利类型

  • 公开/公告日2014-08-26

    原文格式PDF

  • 申请/专利权人 NEIL M. BODIE;

    申请/专利号US200913054738

  • 发明设计人 NEIL M. BODIE;

    申请日2009-07-17

  • 分类号A61K38/10;C07K7/08;C07K7;C07K16/10;

  • 国家 US

  • 入库时间 2022-08-21 16:04:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号